Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0043167 (
pertussis
)
19,595
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Angiotensin II (
ANG
II) stimulates the delayed rectifier K+ current (IK) in neurons cultured from rat hypothalamus and brain stem via AT2 receptors, and this effect involves activation of a Gi protein and protein phosphatase 2A (PP2A). However, there was no evidence that the AT2 receptor involved in this response was the same as the recently cloned AT2 receptor. In the present study, intracellular injection of a 22-amino acid peptide (PEP-22) corresponding to the putative third intracellular loop of the cloned AT2 receptor elicited an increase in IK in cultured neurons that was similar to the effect produced by
ANG
II. Furthermore, this effect of PEP-22 was abolished by
pertussis
toxin (200 ng/ml, 24 h) pretreatment and also by superfusion of the PP2A inhibitor okadaic acid (10 nM), suggesting the involvement of Gi protein and PP2A, respectively. Intracellular injection of a random peptide or normal pipette solution did not affect neuronal IK. This is direct evidence to link the cloned AT2 receptor to a defined response elicited by
ANG
II.
...
PMID:Modulation of the delayed rectifier K+ current in neurons by an angiotensin II type 2 receptor fragment. 784 Jan 57
The effects of angiotensin II (
ANG
II) on growth responses of primary cultures of bovine adrenal glomerulosa cells were studied to explore the mechanism(s) by which
ANG
II leads to hyperplasia and hypertrophy of the glomerulosa layer in sodium deficiency.
ANG
II did not increase [3H]thymidine incorporation during the first 5 days of culture, but mitogenic responses to
ANG
II became evident after longer periods of culture and were most prominent between 8 and 11 days after seeding. At this time, cell cycle analysis showed that
ANG
II increased the proportion of cells in the S phase and did not cause accumulation of cells in the G2 phase. Consistent with this finding,
ANG
II also stimulated proliferation of glomerulosa cells during treatment for 3 days in the presence of 1% serum. The mitogenic effect of
ANG
II was not inhibited by pretreatment with
pertussis
toxin and was mediated by AT1 receptors as indicated by its sensitivity to the subtype-selective antagonist DuP-753. Also, there was no emergence of AT2 receptors in glomerulosa cells during prolonged culture. These results indicate that intracellular mechanisms that mediate growth responses become more active during prolonged culture of glomerulosa cells. Thus, in addition to regulating the steroidogenic and secretory functions of the zona glomerulosa,
ANG
II exerts mitogenic actions that depend on the functional state of the glomerulosa cells.
...
PMID:Growth responses to angiotensin II in bovine adrenal glomerulosa cells. 784 Jan 71
Angiotensin II (
ANG
II) elicits an
ANG
II type 2 (AT2) receptor-mediated increase in outward K+ current (IK; delayed rectifier K+ current) in neurons cocultured from rat hypothalamus and brain stem. Here we have shown that the AT2-receptor-mediated stimulation of neuronal IK by
ANG
II (100 nM) was abolished by pretreatment of cultures with
pertussis
toxin (PTX; 200 ng/ml) and by intracellular application of an antibody against the inhibitory guanine nucleotide (GTP) binding protein (anti-Gi alpha, 1:200). Antibodies against other GTP binding proteins (anti-Go alpha, 1:50 and 1:200; anti-Gq/11 alpha, 1:200) did not alter the AT2-receptor-mediated stimulation of neuronal IK by
ANG
II (100 nM). Furthermore, this effect of
ANG
II (100 nM) was inhibited by the serine/threonine phosphatase inhibitor okadaic acid (1-10 nM) and by anti-type 2A protein phosphatase (PP2A) antibodies but not by the tyrosine phosphatase inhibitor sodium orthovanadate (1 mM). Thus we have identified key components (Gi and PP2A) of the signal transduction pathway that is responsible for the AT2-receptor-mediated stimulation of neuronal K+ currents.
...
PMID:Angiotensin II type 2 receptor stimulation of neuronal K+ currents involves an inhibitory GTP binding protein. 797
Treatment of rabbits with angiotensin-converting enzyme (ACE)-inhibiting drugs increases Na(+)-K+ pump current (Ip) of isolated cardiac myocytes when intracellular Na+ is at near-physiological levels. To examine if effects of ACE inhibitors are related to angiotensin metabolism, we measured Ip in myocytes isolated from rabbits treated with the AT1 receptor antagonist losartan. Ip was increased to levels similar to those after treatment with ACE inhibitors. Exposure of myocytes from captopril-treated rabbits to 10 nM angiotensin II (
ANG
II) for 45 min in vitro reduced Ip to levels similar to those of myocytes from untreated control rabbits. This rapid response to
ANG
II suggests that treatment with captopril had induced a functional change in preexisting pump units rather than synthesis of a new population of pumps. Consistent with this, we could not detect a change in Na(+)-K+ pump subunit mRNAs during treatment with captopril. The decrease in Ip of myocytes from captopril-treated rabbits induced by
ANG
II in vitro was blocked by
pertussis
toxin, bisindolylmaleimide I, and staurosporine. Exposure of myocytes to phorbol 12-myristate 13-acetate induced a decrease in Ip similar to that induced by
ANG
II. Thus ACE inhibitors regulate the Na(+)-K+ pump in myocytes via an effect on angiotensin metabolism. The regulatory mechanism appears to include the AT1 receptor, a G protein, and protein kinase C.
...
PMID:Angiotensin-converting enzyme inhibitors regulate the Na(+)-K+ pump via effects on angiotensin metabolism. 876 43
Angiotensin II (
ANG
II) and arginine vasopressin (AVP) act on area postrema (AP) neurons to modulate the baroreflex. Because activation of AP neurons by either
ANG
II or AVP increases intracellular free Ca2+ concentrations ([Ca2+]i), the goal of this study was to analyze the factors affecting the [Ca2+]i responses to
ANG
II and AVP. Neurons were recovered from 14- to 16-day old rats and studied after 8-14 days in culture by use of the microscopic digital image analysis for fura 2-loaded cells. The effects of
ANG
II (100 nM) and AVP (100 nM) on [Ca2+]i were determined in normal (2 mM) and low (< 10 nM) extracellular Ca2+ concentrations. In 143 of 240 neurons,
ANG
II increased [Ca2+]i 4.65-fold after 20 s, and a similar response was observed in the absence of extracellular Ca2+ (3.65-fold after 20 s). After 60 s of observation, steady-state levels of increased [Ca2+]i were still present under both conditions. Pretreatment with AT1 antagonist or
pertussis
toxin abolished the response to
ANG
II. AVP also increased [Ca2+]i (3.6-fold at peak, 20 s) in normal and low extracellular Ca2+. Pretreatment with AVP V1 antagonist or
pertussis
toxin abolished the response to AVP. This study indicates that
ANG
II-induced increases in [Ca2+]i are independent of extracellular Ca2+ concentrations and involve the activation of AT1 receptors and a
pertussis
toxin-sensitive G protein. Although AVP affects a fewer number of AP neurons, the mechanisms of activation are also independent of extracellular Ca2+ concentration and are mediated by a
pertussis
toxin-sensitive G protein.
...
PMID:Subcellular mechanisms of angiotensin II and arginine vasopressin activation of area postrema neurons. 876 Feb 1
The action of angiotensin II (
ANG
II) was studied in single myocytes from rat portal vein, in which the cytoplasmic Ca++ concentration was estimated by emission from fluorescent dyes and the Ca++ channel current was measured with the whole-cell mode of the patch-clamp technique.
ANG
II stimulated Ca++ channel current through L-type Ca++ channels and initiated a slow and small increase in the cytoplasmic Ca++ concentration in cells in which intracellular Ca++ stores had been depleted by pretreatment with ryanodine and caffeine. Both Ca++ channel current stimulation and Ca++ responses were selectively inhibited by losartan, indicating activation of angiotensin AT1 receptors. Activation of Ca++ channels by
ANG
II was insensitive to treatment with
pertussis
toxin and cholera toxin. Intracellular applications of anti-G alpha q/alpha 11 and anti-phosphatidylinositol antibodies had no effect on the
ANG
II-induced stimulation of Ca++ channel current, indicating that phosphatidylinositol-specific phospholipase C was not involved in this signaling pathway. Down-regulation of protein kinase C and application of an inhibitor of protein kinase C blocked the
ANG
II-induced effects. Tricyclodecan-9-yl xanthogenate (an inhibitor of non-phosphatidylinositol-specific phospholipases C and phospholipases D) but not propranolol (an inhibitor of phospholipase D-derived diacylglycerol formation) suppressed the
ANG
II-induced effects. These data suggest that phosphatidylcholine-specific phospholipase C is involved in the
ANG
II signaling pathway leading to stimulation of L-type Ca++ channels by protein kinase C.
...
PMID:Angiotensin II-mediated activation of L-type calcium channels involves phosphatidylinositol hydrolysis-independent activation of protein kinase C in rat portal vein myocytes. 876 93
Angiotensin II (
ANG
II), a potent growth-promoting factor of vascular smooth muscle cells (VSMC), induces activation of mitogen-activated protein (MAP) kinases and subsequent expression of the c-fos protooncogene in VSMC. However, it remains obscure whether
ANG
II induces activation of the ras protooncogene product (Ras), and if it does, whether Ras is involved in signaling from the
ANG
II receptor to the MAP kinase pathway in VSMC. In cultured VSMC,
ANG
II activated Ras comparably to epidermal growth factor.
ANG
II-induced Ras activation was detectable within 1 min and maximal at 2-5 min. The
ANG
II type 1 (AT1) receptor antagonist, CV-11974, completely inhibited this reaction.
Pertussis
toxin treatment of VSMC inhibited
ANG
II-induced Ras activation by approximately 70% but had no effect on
ANG
II-induced MAP kinase activation and c-fos expression. These results indicate that
ANG
II activates Ras via AT1 receptors, which are predominantly linked to a G protein of the Gi subfamily in VSMC1 and suggest that Ras activation may not be a prerequisite for
ANG
II-induced MAP kinase activation and c-fos expression in this cell type.
...
PMID:Angiotensin II type 1 receptor-mediated activation of Ras in cultured rat vascular smooth muscle cells. 877 Jan 1
The potential mechanisms of angiotensin II (
ANG
II)-induced mitogenesis were studied in a Chinese hamster ovary fibroblast cell line overexpressing the rat vascular type 1a
ANG
II receptor (CHO-AT1a).
ANG
II had potent mitogenic effects in these CHO-AT1a cells, leading to a sustained increase in cell number as well as a dose-dependent increase in DNA synthesis.
ANG
II treatment also induced a biphasic elevation of mitogen-activated protein (MAP) kinase activity of both p42MAPK and p44MAPK with a rapid early peak at 5 min (2- to 6-fold) followed by a second sustained increase that reached a peak at 3 h (1.5- to 3-fold). We have previously shown that the 12-lipoxygenase (12-LO) pathway of arachidonate metabolism plays a key role in
ANG
II-induced growth of vascular smooth muscle and adrenal cells. In the present study,
ANG
II (10(-7) M) increased the formation of the 12-LO product, 12-hydroxyeicosatetraenoic acid (12-HETE).
ANG
II-induced DNA synthesis was inhibited by a specific LO inhibitor, cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC, 10 microM). In contrast, a cyclooxygenase blocker of arachidonate metabolism such as ibuprofen had no effect on
ANG
II-induced DNA synthesis.
ANG
II-induced DNA synthesis was also partially (32%) blocked by
pertussis
toxin (PTX). CDC and PTX also selectively blocked only the late (3 h) peak of
ANG
II-induced MAP kinase activity, suggesting that the late sustained peak of MAP kinase activity may be linked to the mitogenic effect of
ANG
II. Direct addition of 12-HETE (10(-7) M) led to a sustained increase in cell number similar to the effect of
ANG
II. 12-HETE also caused an increase in MAP kinase activity, and 12-HETE effects were blocked by PTX. These results suggest that
ANG
II-induced mitogenic response is associated with sustained MAP kinase activation and that LO activation may play a key role in this process.
...
PMID:Mechanisms of ANG II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase. 889 27
Angiotensin II (
ANG
II) is the most potent and the most physiologically important stimulator of aldosterone synthesis and secretion from the adrenal zona glomerulosa. Because steroidogenesis by adrenal glomerulosa (AG) cells is mediated in part by Ca2+ influx through T- and L-type Ca2+ channels, we evaluated whether T-type Ca2+ channels are regulated by
ANG
II. We observe that
ANG
II enhances T-type Ca2+ current by shifting the voltage dependence of channel activation to more negative potentials. This shift is transduced by the
ANG
II type 1 receptor. The effect of the hormone is not mediated by Ca2+/calmodulin-dependent protein kinase II (CaMKII) as it is not prevented by CaMKII(281-302), a peptide inhibitor of the catalytic region of the kinase. Rather, this shift is mediated by the activation of a G protein, Gi, because it is abolished by cell pretreatment with
pertussis
toxin and by cell dialysis with a monoclonal antibody generated against recombinant Gi alpha. This effect of
ANG
II on T-type Ca2+ channels should increase Ca2+ entry in AG cells at physiologically relevant voltages and result in a sustained increase in aldosterone secretion.
...
PMID:Angiotensin II stimulates T-type Ca2+ channel currents via activation of a G protein, Gi. 889 41
The proliferation and hypertrophy of renal tubular cells are primary features in the progression of both acute and chronic renal disease often indicating a poor prognosis. Angiotensin II (
ANG
II), acting alone or in combination with other growth factors, has been implicated in this process. The aims of this study were to identify the importance of both
ANG
II and serum-derived factors upon cellular DNA synthesis and protein synthesis in renal proximal tubular cells and to identify the roles of the
ANG
II receptor subtypes in these processes together with the underlying intracellular signalling mechanisms involved. Primary cultures of renal proximal tubular cells were prepared from freshly isolated rat kidney cortex. Cells were cultured in either serum-replete Dulbecco's modified Eagle's/Ham's F12 or serum-deplete defined medium containing insulin, hydrocortisone, sodium selenite, transferrin, and tri-iodothyronine. Cells were incubated with
ANG
II (10(-10), 10(-8), 10(-6) M) for 24-120 h either alone or in combination with losartan, PD123319, or
pertussis
toxin. Incubation of proximal tubular cells in the presence of serum and
ANG
II (10(-8) M) induced a significant early (24 h) increase in DNA synthesis, together with a significant late (96 h) increase in protein content. [3H]thymidine uptake increased by 56% (p < 0.001) and total protein content by 23% (p < 0.05). In defined media,
ANG
II (10(-8) M) stimulated protein synthesis only. [3H]uridine uptake, [3H]leucine uptake, and total protein content increased by 25, 57, and 17% (p < 0.05), respectively. In both serum-replete and serum-deplete media, the effects upon protein synthesis of
ANG
II were inhibited by
pertussis
toxin and losartan, but not by PD123319.
ANG
II is clearly a potent stimulator of renal tubular cell DNA and protein synthesis-a response mediated via the AT1 receptor coupled to a
pertussis
toxin sensitive Gi protein.
...
PMID:Selective antagonism of the AT1 receptor inhibits the effect of angiotensin II on DNA and protein synthesis of rat proximal tubular cells. 920 86
<< Previous
1
2
3
4
Next >>